IVD Market Trends Summary

Attention: There is an updated edition available for this report.

IVD Market Trends Summary

In vitro diagnostic (IVD) products continue to see positive sales growth in many categories, while others mature. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. IVD Market Trends Summary features current trends and updates in the worldwide IVD market. Highlights of these updates include:

  • Market developments in developing markets – Latin America, the Middle East and Eastern Europe
  • Effects of PAMA in the US IVD market
  • Effects of US tariffs on the Chinese IVD market
  • Molecular point-of-care market
  • New products receiving with either FDA 510(k) clearance, CLIA waiver or CE marking
  • New developments in tick-borne disease testing
  • Babesiosis testing
  • Development of a point-of-care concussion testing/brain trauma
  • Importance of flu testing – development in over-the-counter (OTC) flu tests
  • Infectious diseases testing – Zika, Ebola and Chagas

  • IVD Trends 2019
    • Introduction
      • Table The Worldwide IVD Market, 2018 -2023 ($millions)
      • Table Regional Distribution of IVD Market, 2019
    • Eastern Europe
    • The Middle East
    • Latin America
    • Molecular Point-of-Care Diagnostics
    • New FDA Clearance, CLIA Waive and CE Mark Products
    • Tick-Borne Diseases
    • Babesiosis
    • New Developments
      • ChemBio Diagnostics, Inc. (Medford, NY)
      • Cue Health, Inc. (San Diego, CA) and Diassess, Inc. (Emeryville, CA)
      • ChromaCode (Carlsbad, CA)
      • Curetis (Holzgerlingen, Germany)
      • Infectious Diseases
    • Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings